Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.53 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.53 |
| ▸ | TSHR | P16473 | 4/20 | 0.53 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.53 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.53 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.43 |
| ▸ | ATM | Q13315 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.39 |
| ▸ | CA9 | Q16790 | 1/20 | 0.39 |
| ▸ | CES2 | O00748 | 2/20 | 0.39 |
| ▸ | CES1 | P23141 | 2/20 | 0.39 |
| ▸ | BCHE | P06276 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29788341 | 1.00 | ALDH1A1 (0.53) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL24672067 | 0.81 | ALDH1A1 (0.41) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL29937128 | 0.81 | CYP1A2 (0.41) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL29428517 | 0.81 | ALDH1A1 (0.50) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL20356021 | 0.81 | CYP1A2 (0.42) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL18380189 | 0.81 | ALDH1A1 (0.41) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL14596479 | 0.81 | ACHE (0.52) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL4959166 | 0.81 | ALDH1A1 (0.50) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL4078324 | 0.81 | JAK2 (0.45) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 | |
| SCHEMBL30706725 | 0.81 | JAK2 (0.45) | ALDH1A1HSD17B10TSHRHPGDCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114773220-B | Rigid double-tail surfactant, preparation method thereof and clean fracturing fluid | 西安阿伯塔资环分析测试技术有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-114773220-A | Rigid double-tail surfactant, preparation method thereof and clean fracturing fluid | 西安阿伯塔资环分析测试技术有限公司 | 2022-07-22 | — | — | CN | claimed |
| CN-114773220-B | Rigid double-tail surfactant, preparation method thereof and clean fracturing fluid | 西安阿伯塔资环分析测试技术有限公司 | 2024-01-26 | — | — | CN | disclosed |
| CN-115991815-A | Halogenated modified prepared photoresist resin material and preparation method thereof | 中国科学院长春应用化学研究所 | 2023-04-21 | — | — | CN | disclosed |
| CN-114773220-A | Rigid double-tail surfactant, preparation method thereof and clean fracturing fluid | 西安阿伯塔资环分析测试技术有限公司 | 2022-07-22 | — | — | CN | disclosed |
| EP-3564245-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | Osaka University (JP) | 2019-11-06 | — | — | EP | disclosed |
| WO-2018123207-A1 | NAPHTHOBISCHALCOGENADIAZOLE DERIVATIVE AND PRODUCTION METHOD THEREFOR | 国立大学法人大阪大学 | 2018-07-05 | — | — | WO | disclosed |
| US-20090221645-A1 | Dihydroimidazothiazole Derivatives | PROSIDION LIMITED (GB) | 2009-09-03 | — | — | US | disclosed |
| EP-1851232-A2 | DIHYDROIMIDAZOTHIAZOLE DERIVATIVES | Prosidion Limited (GB) | 2007-11-07 | — | — | EP | disclosed |
| WO-2006085118-A2 | DIHYDROIMIDAZOTHIAZOLE DERIVATIVES | PROSIDION LIMITED (GB) | 2006-08-17 | — | — | WO | disclosed |
| US-6887533-B2 | Fluorinated oxaanthracenes and their use in liquid-crystal mixtures | CLARIANT INTERNATIONAL, LTD. (CH) | 2005-05-03 | — | — | US | disclosed |
| US-20040245498-A1 | Fluorinated oxaanthracenes and their use in liquid-crystal mixtures | AZ ELECTRONIC MATERIALS (GERMANY) GMBH (DE) | 2004-12-09 | — | — | US | disclosed |
| US-6759103-B2 | NEMATIC, CHOLESTERIC OR CHIRAL SMECTIC LIQUID-CRYSTAL MIXTURES HAVING HIGH ABSOLUTE DIELECTRIC ANISOTROPY VALUES AND WITH A FAVORABLE VISCOSITY/CLEARING POINT RELATIONSHIP; PHOTOSTABILITY; HEAT AND ULTRAVIOLET RADIATION RESISTANCE | CLARIANT FINANCI (BVI) LIMITED (VG) | 2004-07-06 | — | — | US | disclosed |
| US-20030091756-A1 | Nematic, cholesteric or chiral smectic liquid-crystal mixtures having high absolute dielectric anisotropy values and with a favorable viscosity/clearing point relationship; photostability; heat and ultraviolet radiation resistance | CLARIANT INTERNATIONAL LTD. | 2003-05-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221645-A1 | Dihydroimidazothiazole Derivatives | TPH1, HTR3B, HTR1A | ALDH1A1 195/4885HSD17B10 481/4885TSHR 460/4885 |
| US-20040245498-A1 | Fluorinated oxaanthracenes and their use in liquid-crystal mixtures | FRG1, CXCR1, CCR1 | ALDH1A1 821/4885HSD17B10 417/4885TSHR 835/4885 |
| US-20030091756-A1 | Nematic, cholesteric or chiral smectic liquid-crystal mixtures having high absolute dielectric anisotropy values and with a favorable viscosity/clearing point relationship; photostability; heat and ultraviolet radiation resistance | SCO2, CNOT1, HCFC1 | ALDH1A1 1699/4885HSD17B10 805/4885TSHR 4788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.